Related references
Note: Only part of the references are listed.Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2viaintegrated computational approach
Salman Ali Khan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
Nisha Muralidharan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
Robert L. Gottlieb et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Antibodies to watch in 2021
Helene Kaplon et al.
MABS (2021)
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
Wesley B. Cardoso et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
SARS-CoV-2 variants and ending the COVID-19 pandemic
Arnaud Fontanet et al.
LANCET (2021)
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang et al.
NATURE (2021)
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer et al.
NATURE MEDICINE (2021)
Neutralizing Activity of BNT162b2-Elicited Serum
Yang Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Aiping Wu et al.
CELL HOST & MICROBE (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Shuai Xia et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Arguments in favour of remdesivir for treating SARS-CoV-2 infections
Wen-Chien Ko et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China
David S. Hui et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Coronavirus Infections-More Than Just the Common Cold
Catharine I. Paules et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV
Jia Liu et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China
Fei Yu et al.
MICROBES AND INFECTION (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak
Liangjun Chen et al.
EMERGING MICROBES & INFECTIONS (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event
D. Paraskevis et al.
INFECTION GENETICS AND EVOLUTION (2020)
Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein
Naveen Vankadari
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Yung-Fang Tu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A global treatments for coronaviruses including COVID-19
Bahman Yousefi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
Zhen Zhu et al.
JOURNAL OF INFECTION (2020)
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng et al.
JOURNAL OF INFECTION (2020)
The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections
Farhana Musarrat et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease
Donald C. Hall et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Qingxian Cai et al.
ENGINEERING (2020)
Covid-19-The Search for Effective Therapy
Lindsey R. Baden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Delayed Initiation of Remdesivir in a COVID-19-Positive Patient
Emily Hillaker et al.
PHARMACOTHERAPY (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
A systematic review on the ef ficacy and safety of chloroquine for the treatment of COVID-19
Andrea Cortegiani et al.
JOURNAL OF CRITICAL CARE (2020)
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
Abdo A. Elfiky
LIFE SCIENCES (2020)
Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
David A. Jans et al.
CELLS (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
severe Acute Respiratory Syndrome Coronavirus-2 SARS-CoV-2 An Update
Mahendra Pal et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Egor P. Tchesnokov et al.
VIRUSES-BASEL (2019)
Clinical outcomes among hospital patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection
Abdulrahman Mohammed G. Habib et al.
BMC INFECTIOUS DISEASES (2019)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Michael K. Lo et al.
SCIENTIFIC REPORTS (2017)
Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model
Justin G. Julander et al.
ANTIVIRAL RESEARCH (2017)
Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens
Nicole R. Sexton et al.
JOURNAL OF VIROLOGY (2016)
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
Eve-Isabelle Pecheur et al.
JOURNAL OF VIROLOGY (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
BCX4430-A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease
Raymond Taylor et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2016)
Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses
Wahyu N. Wulan et al.
FRONTIERS IN MICROBIOLOGY (2015)
Continuous and Discontinuous RNA Synthesis in Coronaviruses
Isabel Sola et al.
ANNUAL REVIEW OF VIROLOGY, VOL 2 (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model
Justin G. Julander et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
Lisa Oestereich et al.
ANTIVIRAL RESEARCH (2014)
Arbidol as a broad-spectrum antiviral: An update
Julie Blaising et al.
ANTIVIRAL RESEARCH (2014)
Current advancements and potential strategies in the development of MERS-CoV vaccines
Naru Zhang et al.
EXPERT REVIEW OF VACCINES (2014)
Nelfinavir Inhibits Maturation and Export of Herpes Simplex Virus 1
Nene N. Kalu et al.
JOURNAL OF VIROLOGY (2014)
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
Ali S. Omrani et al.
LANCET INFECTIOUS DISEASES (2014)
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Travis K. Warren et al.
NATURE (2014)
The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
Zhinan Jin et al.
PLOS ONE (2013)
Antiviral Activity of Arbidol, a Broad-Spectrum Drug for Use Against Respiratory Viruses, Varies According to Test Conditions
Megan J. Brooks et al.
JOURNAL OF MEDICAL VIROLOGY (2012)
Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
Sander van Boheemen et al.
MBIO (2012)
HIV-1 Assembly, Budding, and Maturation
Wesley I. Sundquist et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
Erik De Clercq
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses
Yasushi Itoh et al.
NATURE (2009)
SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway
Hongliang Wang et al.
CELL RESEARCH (2008)
Respiratory syncytial virus infection in adults
Yoshihiko Murata
CURRENT OPINION IN PULMONARY MEDICINE (2008)
Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted
Yuuki Inoue et al.
JOURNAL OF VIROLOGY (2007)
Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis
Fernando Almazan et al.
JOURNAL OF VIROLOGY (2006)
Arbidol:: a broad-spectrum antiviral that inhibits acute and chronic HCV infection
Yury S. Boriskin et al.
VIROLOGY JOURNAL (2006)
Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3-carboxylates
CS Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Mechanisms of action of ribavirin against distinct viruses
JD Graci et al.
REVIEWS IN MEDICAL VIROLOGY (2006)
Expanding the frontiers of existing antiviral drugs: Possible effects of HIV-1 protease inhibitors against SARS and avian influenza
A Savarino
JOURNAL OF CLINICAL VIROLOGY (2005)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
M Czub et al.
VACCINE (2005)
Sialobiology of influenza molecular mechanism of host range variation of influenza viruses
Y Suzuki
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Treatment of severe acute respiratory syndrome
ST Lai
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
Ultrastructural characterization of SARS coronavirus
CS Goldsmith et al.
EMERGING INFECTIOUS DISEASES (2004)
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
N Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium
MN Matrosovich et al.
JOURNAL OF VIROLOGY (2004)
Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
MJ Brooks et al.
CURRENT OPINION IN PULMONARY MEDICINE (2004)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
Identification of severe acute respiratory syndrome in Canada
SM Poutanen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A major outbreak of severe acute respiratory syndrome in Hong Kong
N Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
